Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2017

09.03.2017 | Retinal Disorders

The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF

verfasst von: F. Treumer, S. Wienand, K. Purtskhvanidze, J. Roider, J. Hillenkamp

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the incidence of pigment epithelial detachment (PED) in age-related macular degeneration (AMD) with submacular hemorrhage (SMH) and its response to treatment with pars plana vitrectomy (ppV), subretinal co-application of recombinant tissue plasminogen activator (rtPA) and anti-VEGF, and an intravitreal gas tamponade.

Methods

Consecutive interventional case series of 132 eyes of 129 patients with neovascular AMD with SMH. All eyes underwent ppV with subretinal co-application of rtPA and bevacizumab followed by a gas tamponade. Postoperatively, two additional intravitreal anti-VEGF injections were applied monthly, followed by intravitreal anti-VEGF injections applied PRN thereafter. PEDs and SMHs were evaluated with SD-OCT pre- and postoperatively.

Results

Preoperatively, 88 of 132 (67%) eyes were examined by OCT, and in 81 of these eyes the RPE could be visualised. A PED was found in 74 (91%) eyes, and no PED was found in five (6%) eyes. Median height of preoperative PED was 503 μm (range 150–1242, n = 65) and reduced to 344 (n = 62) and 306 μm (n = 27) after 3 and 12 months respectively. Two eyes showed a pre-existing rip of the RPE. Postoperatively, a rip was documented in 12 of 128 (9%) eyes. Median height of SMH was 762 μm (range 217–1840), median diameter was 4.3 (1.5-15) disc diameter. A complete displacement of the SMH from the fovea was achieved in 112 of 129 (87%) eyes. Overall, median best-corrected logMAR visual acuity (BCVA) improved significantly from preoperative 1.6 (0.5–2.0, n = 132) to 1.0 (0.2–2.0) 3 (n = 132) and 12 months (n = 74) postoperatively. Excluding eyes with pre-existing macular scars (n = 22), BCVA 3 months postoperatively was 0.8. Height of PED or SMH did not correlate with postoperatively BCVA, while size of SMH showed a mild correlation (rho = 0.25, p = 0.005).

Conclusion

PpV with subretinal co-application of rtPA and bevacizumab and an intravitreal gas tamponade effectively displaces SMH and improves BCVA. Preoperatively, PED is found in the majority of eyes. Height of PED or SMH did not correlate with postoperatively BCVA. Tears of the RPE occur as frequently as in exudative AMD without SMH.
Literatur
1.
Zurück zum Zitat Pauleikhoff D, Löffert D, Spital G et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–538CrossRefPubMed Pauleikhoff D, Löffert D, Spital G et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–538CrossRefPubMed
2.
Zurück zum Zitat Baba T, Kitahashi M, Kubota-Taniai M et al (2012) Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40. Ophthalmologica 228:102–109CrossRefPubMed Baba T, Kitahashi M, Kubota-Taniai M et al (2012) Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40. Ophthalmologica 228:102–109CrossRefPubMed
3.
Zurück zum Zitat Dirani A, Ambresin A, Marchionno L et al (2015) Factors influencing the treatment response of pigment epithelium detachment in age-related macular degeneration. Am J Ophthalmol 160:732–738CrossRefPubMed Dirani A, Ambresin A, Marchionno L et al (2015) Factors influencing the treatment response of pigment epithelium detachment in age-related macular degeneration. Am J Ophthalmol 160:732–738CrossRefPubMed
4.
Zurück zum Zitat Clemens CR, Eter N (2016) Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica 235:1–9CrossRefPubMed Clemens CR, Eter N (2016) Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica 235:1–9CrossRefPubMed
5.
Zurück zum Zitat Treumer F, Klatt C, Roider J, Hillenkamp J (2010) Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol 94:48–53CrossRefPubMed Treumer F, Klatt C, Roider J, Hillenkamp J (2010) Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol 94:48–53CrossRefPubMed
6.
Zurück zum Zitat Treumer F, Roider J, Hillenkamp J (2012) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol 96:708–713CrossRefPubMed Treumer F, Roider J, Hillenkamp J (2012) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol 96:708–713CrossRefPubMed
7.
Zurück zum Zitat González-López JJ, McGowan G, Chapman E, Yorston D (2016) Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye (Lond Engl). doi:10.1038/eye.2016.65 González-López JJ, McGowan G, Chapman E, Yorston D (2016) Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye (Lond Engl). doi:10.​1038/​eye.​2016.​65
8.
Zurück zum Zitat Bach M, Kommerell G (1998) Determining visual acuity using European normal values: scientific principles and possibilities for automatic measurement. Klin Monatsbl Augenheilkd 212:190–195CrossRefPubMed Bach M, Kommerell G (1998) Determining visual acuity using European normal values: scientific principles and possibilities for automatic measurement. Klin Monatsbl Augenheilkd 212:190–195CrossRefPubMed
9.
Zurück zum Zitat Joussen AM, Heussen FMA, Joeres S et al (2006) Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 142:17–30CrossRefPubMed Joussen AM, Heussen FMA, Joeres S et al (2006) Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 142:17–30CrossRefPubMed
10.
Zurück zum Zitat Heimes B, Lommatzsch A, Zeimer M et al (2011) Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme. Graefes Arch Clin Exp Ophthalmol 249:639–644CrossRefPubMed Heimes B, Lommatzsch A, Zeimer M et al (2011) Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme. Graefes Arch Clin Exp Ophthalmol 249:639–644CrossRefPubMed
11.
Zurück zum Zitat Stanescu-Segall D, Balta F, Jackson TL (2016) Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol 61:18–32CrossRefPubMed Stanescu-Segall D, Balta F, Jackson TL (2016) Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol 61:18–32CrossRefPubMed
12.
Zurück zum Zitat Sandhu SS, Manvikar S, Steel DHW (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642PubMedPubMedCentral Sandhu SS, Manvikar S, Steel DHW (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642PubMedPubMedCentral
13.
Zurück zum Zitat Hillenkamp J, Surguch V, Framme C et al (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11CrossRefPubMed Hillenkamp J, Surguch V, Framme C et al (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11CrossRefPubMed
14.
Zurück zum Zitat Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69:397–403CrossRefPubMedPubMedCentral Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69:397–403CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Shah CP, Hsu J, Garg SJ et al (2006) Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142:1070–1072CrossRefPubMed Shah CP, Hsu J, Garg SJ et al (2006) Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142:1070–1072CrossRefPubMed
16.
Zurück zum Zitat Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160–162CrossRefPubMed Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160–162CrossRefPubMed
17.
Zurück zum Zitat Saito M, Kano M, Itagaki K et al (2013) Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol Auckl NZ 7:1287–1289CrossRef Saito M, Kano M, Itagaki K et al (2013) Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol Auckl NZ 7:1287–1289CrossRef
18.
Zurück zum Zitat Carvounis PE, Kopel AC, Benz MS (2007) Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 143:504–505CrossRefPubMed Carvounis PE, Kopel AC, Benz MS (2007) Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 143:504–505CrossRefPubMed
19.
Zurück zum Zitat Chang LK, Flaxel CJ, Lauer AK, Sarraf D (2007) RPE tears after pegaptanib treatment in age-related macular degeneration. Retina Phila Pa 27:857–863CrossRef Chang LK, Flaxel CJ, Lauer AK, Sarraf D (2007) RPE tears after pegaptanib treatment in age-related macular degeneration. Retina Phila Pa 27:857–863CrossRef
20.
Zurück zum Zitat Sarraf D, Chan C, Rahimy E, Abraham P (2013) Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy. Retina Phila Pa 33:1551–1557CrossRef Sarraf D, Chan C, Rahimy E, Abraham P (2013) Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy. Retina Phila Pa 33:1551–1557CrossRef
21.
Zurück zum Zitat Chan CK, Abraham P, Meyer CH et al (2010) Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina Phila Pa 30:203–211CrossRef Chan CK, Abraham P, Meyer CH et al (2010) Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina Phila Pa 30:203–211CrossRef
22.
Zurück zum Zitat Doguizi S, Ozdek S (2014) Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina Phila Pa 34:1156–1162CrossRef Doguizi S, Ozdek S (2014) Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina Phila Pa 34:1156–1162CrossRef
23.
Zurück zum Zitat Clemens CR, Bastian N, Alten F et al (2014) Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol (Copenh) 92:e50–56CrossRef Clemens CR, Bastian N, Alten F et al (2014) Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol (Copenh) 92:e50–56CrossRef
24.
Zurück zum Zitat Clemens CR, Alten F, Eter N (2015) Reading the signs: Microrips as a prognostic sign for impending RPE tear development. Acta Ophthalmol (Copenh) 93:e600–602CrossRef Clemens CR, Alten F, Eter N (2015) Reading the signs: Microrips as a prognostic sign for impending RPE tear development. Acta Ophthalmol (Copenh) 93:e600–602CrossRef
25.
Zurück zum Zitat Mukai R, Sato T, Kishi S (2014) Precursor stage of retinal pigment epithelial tear in age-related macular degeneration. Acta Ophthalmol (Copenh) 92:e407–408CrossRef Mukai R, Sato T, Kishi S (2014) Precursor stage of retinal pigment epithelial tear in age-related macular degeneration. Acta Ophthalmol (Copenh) 92:e407–408CrossRef
26.
Zurück zum Zitat Lehmann B, Heimes B, Gutfleisch M et al (2015) Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE. Ophthalmologe 112:49–56CrossRefPubMed Lehmann B, Heimes B, Gutfleisch M et al (2015) Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE. Ophthalmologe 112:49–56CrossRefPubMed
27.
Zurück zum Zitat Kim JH, Chang YS, Kim JW et al (2014) Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Ophthalmology 121:926–935CrossRefPubMed Kim JH, Chang YS, Kim JW et al (2014) Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Ophthalmology 121:926–935CrossRefPubMed
28.
Zurück zum Zitat CATT Research Group, Martin DF, Maguire MG (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908CrossRef CATT Research Group, Martin DF, Maguire MG (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908CrossRef
Metadaten
Titel
The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF
verfasst von
F. Treumer
S. Wienand
K. Purtskhvanidze
J. Roider
J. Hillenkamp
Publikationsdatum
09.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 6/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3620-2

Weitere Artikel der Ausgabe 6/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.